Nonavalent HPV vaccine's cost-effectiveness for Norway remains to be determined

被引：0
|
作者：
Goodman, Elizabeth [1 ]
Daniels, Vincent [1 ]
Rauscher, Andreas [1 ]
Stanley, Margaret [2 ]
机构：
[1] Merck & Co Inc, Kenilworth, NJ 07033 USA
[2] Univ Cambridge, Pathol, Cambridge, England
来源：
PREVENTIVE MEDICINE | 2021年 / 150卷
关键词：
D O I：
10.1016/j.ypmed.2021.106662
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of nonavalent HPV vaccine in Norway considering current empirical data and validation
    Portnoy, Allison
    Pedersen, Kine
    Trogstad, Lill
    Hansen, Bo T.
    Feiring, Berit
    Laake, Ida
    Smith, Megan A.
    Sy, Stephen
    Nygard, Mari
    Kim, Jane J.
    Burger, Emily A.
    [J]. PREVENTIVE MEDICINE, 2021, 150
  • [2] Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine
    Drolet, Melanie
    Laprise, Jean-Francois
    Boily, Marie-Claude
    Franco, Eduardo L.
    Brisson, Marc
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (09) : 2264 - 2268
  • [3] Cost-effectiveness of nonavalent HPV vaccination in the Netherlands
    Palmer, Cody
    Dolk, Christiaan
    Sabale, Ugne
    Wang, Wei
    Saxena, Kunal
    [J]. EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 312 - 323
  • [4] Estimating the epidemiological impact and cost-effectiveness profile of a nonavalent HPV vaccine in Spain
    De La Fuente, Jesus
    Hernandez Aguado, Juan Jose
    San Martin, Maria
    Ramirez Boix, Paula
    Cedillo Gomez, Sergio
    Lopez, Noelia
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (7-8) : 1949 - 1961
  • [5] THE ESTIMATED IMPACT AND COST-EFFECTIVENESS OF NONAVALENT HPV VACCINATION IN THE UNITED STATES
    Chesson, H. W.
    Markowitz, L. E.
    Hariri, S.
    Ekwueme, D. U.
    Saraiya, M.
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2015, 91 : A61 - A62
  • [6] Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
    Michaeli, Daniel Tobias
    Stoycheva, Sophia
    Marcus, Simon Mashudu
    Zhang, Wenjia
    Michaeli, Julia Caroline
    Michaeli, Thomas
    [J]. CLINICAL DRUG INVESTIGATION, 2022, 42 (04) : 333 - 343
  • [7] Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
    Daniel Tobias Michaeli
    Sophia Stoycheva
    Simon Mashudu Marcus
    Wenjia Zhang
    Julia Caroline Michaeli
    Thomas Michaeli
    [J]. Clinical Drug Investigation, 2022, 42 : 333 - 343
  • [8] QUADRIVALENT HPV VACCINE IN ARGENTINA: COST-EFFECTIVENESS ANALYSIS
    Caporale, J.
    Alcaraz, A.
    Rey-Ares, L.
    Pichon-Riviere, A.
    Bardach, A.
    Augustovski, F.
    Klein, K.
    Tatti, S.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A273 - A273
  • [9] Cost-effectiveness of Interventions to Increase HPV Vaccine Uptake
    Spencer, Jennifer C.
    Brewer, Noel T.
    Trogdon, Justin G.
    Weinberger, Morris
    Coyne-Beasley, Tamera
    Wheeler, Stephanie B.
    [J]. PEDIATRICS, 2020, 146 (06)
  • [10] Public health impact and cost-effectiveness of switching from bivalent to nonavalent vaccine for human papillomavirus in Norway: incorporating the full health impact of all HPV-related diseases
    Diakite, Ibrahim
    Nguyen, Sylvi
    Sabale, Ugne
    Pavelyev, Andrew
    Saxena, Kunal
    Tajik, Athar Ali
    Wang, Wei
    Palmer, Cody
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1085 - 1098
12345